- Home
- EQV vs MREO Comparison
EQV vs MREO Comparison
Compare EQV & MREO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EQV
- MREO
- Stock Information
- Founded
- EQV 2024
- MREO 2015
- Country
- EQV United States
- MREO United Kingdom
- Employees
- EQV N/A
- MREO N/A
- Industry
- EQV
- MREO Biotechnology: Pharmaceutical Preparations
- Sector
- EQV
- MREO Health Care
- Exchange
- EQV Nasdaq
- MREO Nasdaq
- Market Cap
- EQV 461.8M
- MREO 438.8M
- IPO Year
- EQV 2024
- MREO N/A
- Fundamental
- Price
- EQV $10.35
- MREO $1.70
- Analyst Decision
- EQV
- MREO Strong Buy
- Analyst Count
- EQV 0
- MREO 5
- Target Price
- EQV N/A
- MREO $7.20
- AVG Volume (30 Days)
- EQV 120.2K
- MREO 1.4M
- Earning Date
- EQV 01-01-0001
- MREO 08-12-2025
- Dividend Yield
- EQV N/A
- MREO N/A
- EPS Growth
- EQV N/A
- MREO N/A
- EPS
- EQV N/A
- MREO N/A
- Revenue
- EQV N/A
- MREO $500,000.00
- Revenue This Year
- EQV N/A
- MREO N/A
- Revenue Next Year
- EQV N/A
- MREO $38.38
- P/E Ratio
- EQV $50.45
- MREO N/A
- Revenue Growth
- EQV N/A
- MREO N/A
- 52 Week Low
- EQV $9.88
- MREO $1.47
- 52 Week High
- EQV $10.74
- MREO $5.02
- Technical
- Relative Strength Index (RSI)
- EQV 40.69
- MREO 44.90
- Support Level
- EQV $10.35
- MREO $1.64
- Resistance Level
- EQV $10.40
- MREO $1.78
- Average True Range (ATR)
- EQV 0.06
- MREO 0.09
- MACD
- EQV -0.00
- MREO 0.03
- Stochastic Oscillator
- EQV 6.71
- MREO 74.19
About EQV EQV Ventures Acquisition Corp.
EQV Ventures Acquisition Corp is a blank check company.
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).